-
Improving Lesion Segmentation in FDG-18 Whole-Body PET/CT scans using Multilabel approach: AutoPET II challenge
Authors:
Gowtham Krishnan Murugesan,
Diana McCrumb,
Eric Brunner,
Jithendra Kumar,
Rahul Soni,
Vasily Grigorash,
Stephen Moore,
Jeff Van Oss
Abstract:
Automatic segmentation of lesions in FDG-18 Whole Body (WB) PET/CT scans using deep learning models is instrumental for determining treatment response, optimizing dosimetry, and advancing theranostic applications in oncology. However, the presence of organs with elevated radiotracer uptake, such as the liver, spleen, brain, and bladder, often leads to challenges, as these regions are often misiden…
▽ More
Automatic segmentation of lesions in FDG-18 Whole Body (WB) PET/CT scans using deep learning models is instrumental for determining treatment response, optimizing dosimetry, and advancing theranostic applications in oncology. However, the presence of organs with elevated radiotracer uptake, such as the liver, spleen, brain, and bladder, often leads to challenges, as these regions are often misidentified as lesions by deep learning models. To address this issue, we propose a novel approach of segmenting both organs and lesions, aiming to enhance the performance of automatic lesion segmentation methods. In this study, we assessed the effectiveness of our proposed method using the AutoPET II challenge dataset, which comprises 1014 subjects. We evaluated the impact of inclusion of additional labels and data in the segmentation performance of the model. In addition to the expert-annotated lesion labels, we introduced eight additional labels for organs, including the liver, kidneys, urinary bladder, spleen, lung, brain, heart, and stomach. These labels were integrated into the dataset, and a 3D UNET model was trained within the nnUNet framework. Our results demonstrate that our method achieved the top ranking in the held-out test dataset, underscoring the potential of this approach to significantly improve lesion segmentation accuracy in FDG-18 Whole-Body PET/CT scans, ultimately benefiting cancer patients and advancing clinical practice.
△ Less
Submitted 2 November, 2023;
originally announced November 2023.
-
The AIMI Initiative: AI-Generated Annotations for Imaging Data Commons Collections
Authors:
Gowtham Krishnan Murugesan,
Diana McCrumb,
Mariam Aboian,
Tej Verma,
Rahul Soni,
Fatima Memon,
Keyvan Farahani,
Linmin Pei,
Ulrike Wagner,
Andrey Y. Fedorov,
David Clunie,
Stephen Moore,
Jeff Van Oss
Abstract:
The Image Data Commons (IDC) contains publicly available cancer radiology datasets that could be pertinent to the research and development of advanced imaging tools and algorithms. However, the full extent of its research capabilities is limited by the fact that these datasets have few if any, annotations associated with them. Through this study with the Artificial Intelligence (AI) AI in Medical…
▽ More
The Image Data Commons (IDC) contains publicly available cancer radiology datasets that could be pertinent to the research and development of advanced imaging tools and algorithms. However, the full extent of its research capabilities is limited by the fact that these datasets have few if any, annotations associated with them. Through this study with the Artificial Intelligence (AI) AI in Medical Imaging (AIMI) initiative, we produced high-quality, AI-generated imaging annotations of tissues, organs, and/or cancers for 11 distinct medical imaging collections from the IDC. These collections have a variety of image modalities, computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET) imaging modalities. Furthermore, the imaging collections cover various body parities, such as the chest, breast, kidneys, prostate, and liver. Both publicly available and novel AI algorithms were adopted and further developed using open-sourced data coupled with expert annotations to create the AI-generated annotations. A portion of the AI annotations were reviewed and corrected by a radiologist to assess the AI model's performance. Both the AI's and the radiologist's annotations conformed to DICOM standards for seamless integration into the IDC collections as third-party analyses. All the models and datasets (images and annotations) are publicly accessible.
△ Less
Submitted 21 November, 2023; v1 submitted 23 October, 2023;
originally announced October 2023.
-
QU-BraTS: MICCAI BraTS 2020 Challenge on Quantifying Uncertainty in Brain Tumor Segmentation - Analysis of Ranking Scores and Benchmarking Results
Authors:
Raghav Mehta,
Angelos Filos,
Ujjwal Baid,
Chiharu Sako,
Richard McKinley,
Michael Rebsamen,
Katrin Datwyler,
Raphael Meier,
Piotr Radojewski,
Gowtham Krishnan Murugesan,
Sahil Nalawade,
Chandan Ganesh,
Ben Wagner,
Fang F. Yu,
Baowei Fei,
Ananth J. Madhuranthakam,
Joseph A. Maldjian,
Laura Daza,
Catalina Gomez,
Pablo Arbelaez,
Chengliang Dai,
Shuo Wang,
Hadrien Reynaud,
Yuan-han Mo,
Elsa Angelini
, et al. (67 additional authors not shown)
Abstract:
Deep learning (DL) models have provided state-of-the-art performance in various medical imaging benchmarking challenges, including the Brain Tumor Segmentation (BraTS) challenges. However, the task of focal pathology multi-compartment segmentation (e.g., tumor and lesion sub-regions) is particularly challenging, and potential errors hinder translating DL models into clinical workflows. Quantifying…
▽ More
Deep learning (DL) models have provided state-of-the-art performance in various medical imaging benchmarking challenges, including the Brain Tumor Segmentation (BraTS) challenges. However, the task of focal pathology multi-compartment segmentation (e.g., tumor and lesion sub-regions) is particularly challenging, and potential errors hinder translating DL models into clinical workflows. Quantifying the reliability of DL model predictions in the form of uncertainties could enable clinical review of the most uncertain regions, thereby building trust and paving the way toward clinical translation. Several uncertainty estimation methods have recently been introduced for DL medical image segmentation tasks. Develo** scores to evaluate and compare the performance of uncertainty measures will assist the end-user in making more informed decisions. In this study, we explore and evaluate a score developed during the BraTS 2019 and BraTS 2020 task on uncertainty quantification (QU-BraTS) and designed to assess and rank uncertainty estimates for brain tumor multi-compartment segmentation. This score (1) rewards uncertainty estimates that produce high confidence in correct assertions and those that assign low confidence levels at incorrect assertions, and (2) penalizes uncertainty measures that lead to a higher percentage of under-confident correct assertions. We further benchmark the segmentation uncertainties generated by 14 independent participating teams of QU-BraTS 2020, all of which also participated in the main BraTS segmentation task. Overall, our findings confirm the importance and complementary value that uncertainty estimates provide to segmentation algorithms, highlighting the need for uncertainty quantification in medical image analyses. Finally, in favor of transparency and reproducibility, our evaluation code is made publicly available at: https://github.com/RagMeh11/QU-BraTS.
△ Less
Submitted 23 August, 2022; v1 submitted 19 December, 2021;
originally announced December 2021.
